Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 3.55 is 255% above its estimated 5-year average of 1.00, near the high end of its estimated 5-year range (0.40–4.30).
As of 2026-10-06T16:16:17.020Z. 95.73% above its estimated 12-month average of 1.81.
Calculation as of: 2026-10-06T16:16:17.020Z.
Quote observation: 2026-10-06T16:13:31.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: de79f37dd28b2444b736b49afd5c51197d32905f82d346da53a8fc0bd72d8f0e
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
3.55
PS RATIO AVG TTM
1.81
PS RATIO AVG 3Y
1.12
PS RATIO AVG 5Y
1.00
PS RATIO AVG 10Y
1.60
PS RATIO AVG 15Y
1.90
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+95.73%
CURRENT VS 3Y AVG
+215.57%
CURRENT VS 5Y AVG
+255.46%
CURRENT VS 10Y AVG
+122.21%
CURRENT VS 15Y AVG
+86.93%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.20
median of 496 covered companies
CURRENT VS SECTOR MEDIAN
-15.38%
vs the sector median at left
Cumberland Pharmaceuticals Inc.
Market Cap
$111.02M
PS Ratio
3.55
TTM Avg
1.81
3Y Avg
1.12
5Y Avg
1.00
Market Cap
$107.65M
PS Ratio
N/A
TTM Avg
119.38
3Y Avg
60.79
5Y Avg
244.46
Market Cap
$108.87M
PS Ratio
N/A
TTM Avg
2.32
3Y Avg
2.32
5Y Avg
2.32
Market Cap
$109.37M
PS Ratio
N/A
TTM Avg
46.19
3Y Avg
46.23
5Y Avg
46.23
Market Cap
$104.68M
PS Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$110.11M
PS Ratio
65.93
TTM Avg
60.78
3Y Avg
38.49
5Y Avg
33.17
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cumberland Pharmaceuticals Inc. (CPIX) | $111.02M | 3.55 | 1.81 | 1.12 | 1.00 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $107.65M | N/A | 119.38 | 60.79 | 244.46 |
| Immunic, Inc. (IMUX)vs › | $108.82M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $108.87M | N/A | 2.32 | 2.32 | 2.32 |
| Outlook Therapeutics, Inc. (OTLK)vs › | $109.37M | N/A | 46.19 | 46.23 | 46.23 |
| Definitive Healthcare Corp. (DH)vs › | $105.13M | 0.45 | 0.67 | 1.87 | 5.03 |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | N/A | N/A | N/A | N/A |
| Insight Molecular Diagnostics Inc. (IMDX)vs › | $110.11M | 65.93 | 60.78 | 38.49 | 33.17 |
| Apyx Medical Corporation (APYX)vs › | $110.75M | 1.90 | 2.94 | 1.80 | 3.05 |
| BGM Group Ltd. (BGM)vs › | $111.52M | N/A | N/A | N/A | N/A |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $8,292,362 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-07 |
| Q4 FY2025Period ended 2025-12-31 | $13,678,651 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-09 |
| Q1 FY2026Period ended 2026-03-31 | $9,131,317 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $166,458 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $31,268,788 |
Current P/S: $111,024,771 market capitalization ÷ $31,268,788 TTM revenue = 3.55x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:13:31.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 3.55, P/S is above its estimated 17-year median — higher than 95% of readings in its estimated 17-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 17-year low
0.40
median
2.25
estimated 17-year high
7.60
P/S Ratio
3.55
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 3.40 |
| 2026-10-02 | 3.54 |
| 2026-10-01 | 3.60 |
| 2026-09-30 | 3.75 |
| 2026-09-29 | 3.67 |
| 2026-09-28 | 3.70 |
| 2026-09-25 | 3.65 |
| 2026-09-24 | 3.84 |
| 2026-09-23 | 3.80 |
| 2026-09-22 | 3.93 |
| 2026-09-21 | 3.64 |
| 2026-09-18 | 3.51 |
| 2026-09-17 | 3.44 |
| 2026-09-16 | 3.34 |
| 2026-09-15 | 3.18 |
| 2026-09-14 | 3.21 |
| 2026-09-11 | 3.06 |
| 2026-09-10 | 3.10 |
| 2026-09-09 | 3.01 |
| 2026-09-08 | 3.17 |
| 2026-09-04 | 3.25 |
| 2026-09-03 | 3.23 |
| 2026-09-02 | 3.12 |
| 2026-09-01 | 3.14 |
| 2026-08-31 | 3.21 |
| 2026-08-28 | 4.05 |
| 2026-08-27 | 4.14 |
| 2026-08-26 | 4.30 |
| 2026-08-25 | 4.17 |
| 2026-08-24 | 3.76 |
| 2026-08-21 | 3.67 |
| 2026-08-20 | 3.59 |
| 2026-08-19 | 3.67 |
| 2026-08-18 | 3.66 |
| 2026-08-17 | 3.68 |
| 2026-08-14 | 3.73 |
| 2026-08-13 | 3.79 |
| 2026-08-12 | 3.79 |
| 2026-08-11 | 3.81 |
| 2026-08-10 | 3.73 |
| 2026-08-07 | 2.78 |
| 2026-08-06 | 2.74 |
| 2026-08-05 | 2.69 |
| 2026-08-04 | 2.77 |
| 2026-08-03 | 2.56 |
| 2026-07-31 | 2.38 |
| 2026-07-30 | 2.40 |
| 2026-07-29 | 2.38 |
| 2026-07-28 | 2.43 |
| 2026-07-27 | 2.51 |
| 2026-07-24 | 2.36 |
| 2026-07-23 | 2.49 |
| 2026-07-22 | 2.54 |
| 2026-07-21 | 2.80 |
| 2026-07-20 | 2.60 |
| 2026-07-17 | 2.44 |
| 2026-07-16 | 2.73 |
| 2026-07-15 | 2.78 |
| 2026-07-14 | 2.49 |
| 2026-07-13 | 2.33 |
| 2026-07-10 | 2.12 |
| 2026-07-09 | 2.15 |
| 2026-07-08 | 2.23 |
| 2026-07-07 | 2.24 |
| 2026-07-06 | 2.20 |
| 2026-07-02 | 2.27 |
| 2026-07-01 | 2.54 |
| 2026-06-30 | 2.31 |
| 2026-06-29 | 2.44 |
| 2026-06-26 | 2.41 |
| 2026-06-25 | 2.13 |
| 2026-06-24 | 2.16 |
| 2026-06-23 | 2.08 |
| 2026-06-22 | 1.99 |
| 2026-06-18 | 2.04 |
| 2026-06-17 | 2.00 |
| 2026-06-16 | 2.02 |
| 2026-06-15 | 2.00 |
| 2026-06-12 | 2.00 |
| 2026-06-11 | 2.02 |
| 2026-06-10 | 1.95 |
| 2026-06-09 | 2.04 |
| 2026-06-08 | 2.09 |
| 2026-06-05 | 2.07 |
| 2026-06-04 | 2.08 |
| 2026-06-03 | 2.00 |
| 2026-06-02 | 2.06 |
| 2026-06-01 | 2.03 |
| 2026-05-29 | 2.19 |
| 2026-05-28 | 2.13 |
| 2026-05-27 | 2.09 |
| 2026-05-26 | 2.06 |
| 2026-05-22 | 2.09 |
| 2026-05-21 | 1.97 |
| 2026-05-20 | 1.97 |
| 2026-05-19 | 1.93 |
| 2026-05-18 | 1.83 |
| 2026-05-15 | 1.95 |
| 2026-05-14 | 1.76 |
| 2026-05-13 | 1.73 |
| 2026-05-12 | 1.62 |
| 2026-05-11 | 1.63 |
| 2026-05-08 | 1.57 |
| 2026-05-07 | 1.44 |
| 2026-05-06 | 1.47 |
| 2026-05-05 | 1.53 |
| 2026-05-04 | 1.52 |
| 2026-05-01 | 1.46 |
| 2026-04-30 | 1.41 |
| 2026-04-29 | 1.41 |
| 2026-04-28 | 1.44 |
| 2026-04-27 | 1.41 |
| 2026-04-24 | 1.36 |
| 2026-04-23 | 1.31 |
| 2026-04-22 | 1.02 |
| 2026-04-21 | 1.02 |
| 2026-04-20 | 1.06 |
| 2026-04-17 | 1.09 |
| 2026-04-16 | 1.04 |
| 2026-04-15 | 1.08 |
| 2026-04-14 | 1.07 |
| 2026-04-13 | 1.05 |
| 2026-04-10 | 1.04 |
| 2026-04-09 | 1.04 |
| 2026-04-08 | 1.05 |
| 2026-04-07 | 1.03 |
| 2026-04-06 | 1.04 |
| 2026-04-02 | 1.06 |
| 2026-04-01 | 1.04 |
| 2026-03-31 | 1.09 |
| 2026-03-30 | 1.05 |
| 2026-03-27 | 1.03 |
| 2026-03-26 | 1.09 |
| 2026-03-25 | 1.13 |
| 2026-03-24 | 1.05 |
| 2026-03-23 | 1.02 |
| 2026-03-20 | 0.95 |
| 2026-03-19 | 0.97 |
| 2026-03-18 | 0.94 |
| 2026-03-17 | 1.01 |
| 2026-03-16 | 1.03 |
| 2026-03-13 | 1.02 |
| 2026-03-12 | 1.04 |
| 2026-03-11 | 1.03 |
| 2026-03-10 | 1.06 |
| 2026-03-09 | 1.15 |
| 2026-03-06 | 1.27 |
| 2026-03-05 | 1.28 |
| 2026-03-04 | 1.33 |
| 2026-03-03 | 1.66 |
| 2026-03-02 | 1.75 |
| 2026-02-27 | 1.78 |
| 2026-02-26 | 1.62 |
| 2026-02-25 | 1.49 |
| 2026-02-24 | 1.42 |
| 2026-02-23 | 1.39 |
| 2026-02-20 | 1.41 |
| 2026-02-19 | 1.42 |
| 2026-02-18 | 1.42 |
| 2026-02-17 | 1.39 |
| 2026-02-13 | 1.41 |
| 2026-02-12 | 1.37 |
| 2026-02-11 | 1.40 |
| 2026-02-10 | 1.40 |
| 2026-02-09 | 1.39 |
| 2026-02-06 | 1.42 |
| 2026-02-05 | 1.30 |
| 2026-02-04 | 1.43 |
| 2026-02-03 | 1.37 |
| 2026-02-02 | 1.40 |
| 2026-01-30 | 1.36 |
| 2026-01-29 | 1.34 |
| 2026-01-28 | 1.39 |
| 2026-01-27 | 1.35 |
| 2026-01-26 | 1.36 |
| 2026-01-23 | 1.42 |
| 2026-01-22 | 1.46 |
| 2026-01-21 | 1.59 |
| 2026-01-20 | 1.71 |
| 2026-01-16 | 1.68 |
| 2026-01-15 | 1.72 |
| 2026-01-14 | 1.77 |
| 2026-01-13 | 1.70 |
| 2026-01-12 | 1.71 |
| 2026-01-09 | 1.79 |
| 2026-01-08 | 1.75 |
| 2026-01-07 | 1.88 |
| 2026-01-06 | 1.71 |
| 2026-01-05 | 1.45 |
| 2026-01-02 | 1.44 |
| 2025-12-31 | 1.44 |
| 2025-12-30 | 1.43 |
| 2025-12-29 | 1.47 |
| 2025-12-26 | 1.49 |
| 2025-12-24 | 1.52 |
| 2025-12-23 | 1.54 |
| 2025-12-22 | 1.58 |
| 2025-12-19 | 1.60 |
| 2025-12-18 | 1.59 |
| 2025-12-17 | 1.41 |
| 2025-12-16 | 1.29 |
| 2025-12-15 | 1.08 |
| 2025-12-12 | 0.92 |
| 2025-12-11 | 0.90 |
| 2025-12-10 | 0.91 |
| 2025-12-09 | 0.82 |
| 2025-12-08 | 0.79 |
| 2025-12-05 | 0.87 |
| 2025-12-04 | 0.85 |
| 2025-12-03 | 0.83 |
| 2025-12-02 | 0.78 |
| 2025-12-01 | 0.79 |
| 2025-11-28 | 0.82 |
| 2025-11-26 | 0.80 |
| 2025-11-25 | 0.76 |
| 2025-11-24 | 0.75 |
| 2025-11-21 | 0.72 |
| 2025-11-20 | 0.69 |
| 2025-11-19 | 0.70 |
| 2025-11-18 | 0.71 |
| 2025-11-17 | 0.69 |
| 2025-11-14 | 0.76 |
| 2025-11-13 | 0.76 |
| 2025-11-12 | 0.78 |
| 2025-11-11 | 0.72 |
| 2025-11-10 | 0.72 |
| 2025-11-07 | 0.76 |
| 2025-11-06 | 0.78 |
| 2025-11-05 | 0.83 |
| 2025-11-04 | 0.95 |
| 2025-11-03 | 0.98 |
| 2025-10-31 | 1.06 |
| 2025-10-30 | 1.14 |
| 2025-10-29 | 1.16 |
| 2025-10-28 | 1.17 |
| 2025-10-27 | 1.13 |
| 2025-10-24 | 1.24 |
| 2025-10-23 | 1.25 |
| 2025-10-22 | 1.23 |
| 2025-10-21 | 1.29 |
| 2025-10-20 | 1.27 |
| 2025-10-17 | 1.22 |
| 2025-10-16 | 1.23 |
| 2025-10-15 | 1.22 |
| 2025-10-14 | 1.20 |
| 2025-10-13 | 1.19 |
| 2025-10-10 | 1.23 |
| 2025-10-09 | 1.26 |
| 2025-10-08 | 1.31 |
| 2025-10-07 | 1.27 |
| 2025-10-06 | 1.10 |
| 2025-10-03 | 1.11 |
| 2025-10-02 | 1.15 |
| 2025-10-01 | 1.11 |
| 2025-09-30 | 1.11 |
| 2025-09-29 | 1.12 |
| 2025-09-26 | 1.10 |
| 2025-09-25 | 1.08 |
| 2025-09-24 | 1.09 |
| 2025-09-23 | 1.06 |
Showing the most recent 260 of 4,313 data points. The chart above shows the full history.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.